Effects of different combustion modes on the thermal efficiency and emissions of a diesel pilot-ignited natural gas engine under low-medium loads

Research on dual-fuel(DF)engines has become increasingly important as engine manufacturers seek to reduce carbon dioxide emissions.There are significant advantages of using diesel pilot-ignited natural gas engines as DF engines.However,different combustion modes exist due to variations in the formation of the mixture.This research used a simulation model and numerical simulations to explore the combustion characteristics of high-pressure direct injection(HPDI),partially premixed compression ignition(PPCI),and double pilot injection premixed compression ignition(DPPCI)combustion modes under a low-medium load.The results revealed that the DPPCI combustion mode provides higher gross indicated thermal efficiency and more acceptable total hydrocarbon(THC)emission levels than the other modes.Due to its relatively good performance,an experimental study was conducted on the DPPCI mode engine to evaluate the impact of the diesel dual-injection strategy on the combustion process.In the DPPCI mode,a delay in the second pilot ignition injection time increased THC emissions(a maximum value of 4.27g/(kW·h)),decreased the emission of nitrogen oxides(a maximum value of 7.64 g/(kW·h)),increased and then subsequently decreased the gross indicated thermal efficiency values,which reached 50.4%under low-medium loads.

Gut Microbiota Brings a Novel Way to Illuminate Mechanisms of Natural Products in vivo

Poor bioavailability and undefined major/direct targets are two major obstacles for herbal medicines and natural products（NPs） to elucidate their precise mechanisms in vivo. Gut microbiota is an important bridge between eukayotic body and environment, which can interact with a majority of medicines with poor bioavailability and mediate their in vivo pharmacological activities. There are two main modes through which gut microbiota may mediate the pharmacological effects of NPs. First, gut microbiota catabolizes the NPs in herbal medicines into secondary metabolites with higher bioavialability and/or higher activity, facilitating the NPs enter circulation and exert beneficial impact at the pathological spot. Second, herbal medicines and NPs can favorably shift the compositional structure of gut microbiota, thereby performing remote functions to diseased organs/tissues via the systemic impaction of gut microbiota. In this review, the potential pathways were summarized through which gut microbes facilitate the pharmacological functions of herbal medicines and NPs and highlight the significance of gut microbiota in clarifying the in vivo mechanisms of herbal medicines and NPs.